Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,143
Total Claims
$1.5M
Drug Cost
2,144
Beneficiaries
$719
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+25%
Opioid rate vs peers
57.3% vs 45.9% avg
+49%
Cost per patient vs peers
$719 vs $483 avg
+23%
Brand preference vs peers
5.1% vs 4.1% avg
Opioid Prescribing
57.3%
Opioid Rate
14,409
Opioid Claims
$757K
Opioid Cost
12.7%
Long-Acting Rate
This provider's opioid prescribing rate of 57.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 1,278 claims · $441K
Generic: 23,865 claims · $1.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Hydrocodone/Acetaminophen | 8,029 | $323K |
| Fluocinonide | 455 | $115K |
| Lidocaine | 386 | $113K |
| Oxycodone Myristate | 226 | $101K |
| Oxycodone Hcl/Acetaminophen | 1,648 | $71K |
| Betamethasone/Propylene Glyc | 164 | $71K |
| Oxycodone Hcl/Acetaminophen | 12 | $63K |
| Naloxegol Oxalate | 116 | $51K |
| Buprenorphine Hcl/Naloxone Hcl | 148 | $50K |
| Linaclotide | 74 | $41K |
| Methylnaltrexone Bromide | 16 | $40K |
| Buprenorphine Hcl | 39 | $35K |
| Gabapentin | 1,928 | $32K |
| Naloxone Hcl | 338 | $29K |
| Morphine Sulfate | 1,106 | $27K |
Prescribing Profile
57
Unique Drugs
12.0
Anomaly Score
Patient Profile
67
Avg Age
69%
Female
2.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About